one thought on “chess grandmasters show the same longevity advantage as elite athletes”
.
.
richard lipton, md, director, montefiore headache center; edwin s. lowe professor and vice chairman of neurology, albert einstein college of medicine.
.
.
fremanezumab has completed phase iii trials and is under review by the fda to prevent migraine and
.